BioIntelliSense, a startup with backers including UCHealth and Royal Philips, recently raised $45 million. The company began marketing its sticker-like device to monitor patients’ vitals last year after getting FDA clearance at the end of 2019.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,